battle of glp-1 delivery technologies Designing delivery: structural perspectives and formulation approaches for optimized therapy battle of glp-1 delivery technologies

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are gaining increasing attention as first-line agents for the treatment of diabetes and obesity, and with their potential to improve the muscle mass and function, they provide new ideas for the treatment of sarcopenia

Read more: #clinicaltrials #clinicalresearch #cvd #glp1

GLP-1GLP-1GLP-1BS

This review aims to summarize the mechanistic and therapeutic evidence for GLP-1 RAs in targeting key aging processes and their potential to restore cellular homeostasis and enhance healthspan

We are thrilled to announce the launch of our compounded Semaglutide in a single-dose pre-filled glass syringes